Tag:

Eli Lilly

Novo Nordisk shares surge on strong weight-loss pill sales

06 May 2026-15:55
Lilly’s new weight loss pill sees rising demand

01 May 2026-15:14
Eli Lilly shares surge after strong earnings beat

Eli Lilly reported first-quarter earnings and revenue that exceeded Wall Street expectations on Thursday and raised its full-year sales outlook by $2 billion, driven by strong demand for its obesity and diabetes treatments Zepbound and Mounjaro.

30 Apr 2026-15:51
Amazon enters weight-loss drug market with new GLP-1 service

Amazon has officially stepped deeper into the booming weight-loss drug market, launching a new GLP-1 treatment program designed to make obesity care faster, more convenient, and more accessible for patients.

22 Apr 2026-11:22
Eli Lilly close to acquiring Kelonia Therapeutics

20 Apr 2026-11:26
Eli Lilly set to acquire Centessa Pharma in $6.3B deal

31 Mar 2026-16:16
Novo Nordisk cuts Wegovy prices in US plan

Novo Nordisk is launching discounted subscription plans for its weight-loss drug Wegovy in the United States, as competition intensifies in the fast-growing obesity treatment market.

31 Mar 2026-15:58
Novo Nordisk shares fall as Lilly stock climbs

Shares of Novo Nordisk plunged 15% on Monday after the company announced that its next-generation obesity drug failed to meet a key trial objective against a rival treatment from Eli Lilly.

23 Feb 2026-15:15
Novo Nordisk falls behind Lilly in obesity drug race

Novo Nordisk said on Monday that its next-generation obesity treatment CagriSema proved less effective than tirzepatide, developed by Eli Lilly, in a head-to-head clinical trial — marking a setback in the competitive race for dominance in the fast-growing weight-loss drug market.

23 Feb 2026-14:22
Lilly bets on India as global supply hub

Eli Lilly is looking to position India as a key hub in its global supply chain as sales of its blockbuster weight-loss drug Mounjaro surge in the country.

17 Feb 2026-14:20